
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Author(s) -
Robert T. O’Donnell,
Shiloh M. Martin,
Yunpeng Ma,
William C. Zamboni,
Joseph M. Tuscano
Publication year - 2010
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/s2c3-2861
Subject(s) - doxorubicin , cd22 , liposome , cancer research , medicine , nanotechnology , materials science , chemotherapy , lymphoma , cd20